Estrogen (E2) and glucocorticoid (Gc) effects on microglia and Aβ clearance in vitro and in vivo

Neurochemistry International

Volumn 39, Issue 5-6, 2001, Pages 435-448

  Harris White, Marni E ^a,b   Chu, Teresa ^a,b   Miller, Sheryl A ^a,b   Simmons, Mychica ^a,b   Teter, Bruce ^a,b   Nash, Darrell ^a,b   Cole, Greg M ^a,b,c   Frautschy, Sally A ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Activated microglia ( glia); Beta amyloid (A ); Degradation; Estrogen (E2); Glucocorticoid (Gc); Nitric oxide; Phagocytosis; Phosphotyrosine

Indexed keywords

AMYLOID BETA PROTEIN; DEXAMETHASONE; ESTRADIOL; ESTROGEN; GLUCOCORTICOID; NITRIC OXIDE; PREDNISOLONE; STEROID;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CELL LINE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOTOXICITY; DRUG EFFECT; ENTORHINAL CORTEX; FEEDING; FEMALE; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LONG TERM EXPOSURE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN TRANSPORT; QUANTITATIVE ASSAY; RAT; STAINING;

AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CELL LINE; CELL SURVIVAL; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; GLUCOCORTICOIDS; MICE; MICROGLIA; NITRIC OXIDE; PREDNISOLONE; RATS; RATS, SPRAGUE-DAWLEY; TOXINS, BIOLOGICAL;

EID: 0034807776     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(01)00051-1     Document Type: Article

References (67)

1. Inflammation and Alzheimer's disease
2. Scavenging of Alzheimer's amyloid β-protein by microglia in culture
3. Identification and localization of Chylamydia pneumoniae in the Alzheimer's brain
4. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of alzheimer disease
5. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and Histamine H2 blocking drugs
6. Alzheimer's disease in the NAS-NRC Registry of aging twin veterans. II. Longitudinal findings in a pilot series
7. Progesterone regulation of estradiol-induced rat uterine secretory protein, complement C3
8. Antiinflammatory effects of estrogen on μglial activation
9. Preferential adsorption internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, A B1-42, in differentiated PC12 cells
10. MIF as a glucocorticoid-induced modulator of cytokine production
11. Glia: The not so innocent bystanders
12. Effect of chloroquine and leupeptin on intracellular accumulation of amyloid-beta (Aβ) 1-42 peptide in a murine N9 μglial cell line
13. Uptake, degradation, and release of fibrillar and soluble forms of alzheimer's amyloid beta-peptide by μglial cells
14. Degradation of β-amyloid peptide by μglia
15. Inducible nitric oxide synthase activity of cloned murine μglial cells
16. Estrogens, the immune response, and autoimmunity
17. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages
18. Female sex steroids: Effects upon μglial cell activation
19. Inhibition of μglial cell activation by cortisol
20. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity
21. Estrogen regulates the IFN-gamma promoter
22. Ultrastructure of the μglia that phagocytose amyloid and the μglia that produce beta-amyloid fibrils
23. Rodent models of Alzheimer's disease: Rat Aβ infusion approaches to amyloid deposits
24. μglial response to amyloid plaques in APPsw transgenic mice
25. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages
26. Growth control of cultured μglia
27. Glial turnover in the injured CNS: Activated μglia undergo delayed DNA fragmentation following peripheral nerve injury
28. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain
29. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase
30. Effects of TGFβs(1-3) on Aβ deposition and inflammation and cell-targeting in organotypic hippocampal slice cultures
31. Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: Ultradian secretory pulsatility and diurnal variation
32. Physiological concentrations of 17beta-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor mediated system
33. Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease
34. Modification of μglial reactivity in MAPP/MPS1 transgenic mice using NCX-2216 (nitroflurbiprofen)
35. Aβ peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease
36. Migration inhibitory factor induces killing of leishmania major by macrophages: Dependence on reactive nitrogen intermediates and endogenous TNF-alpha
37. The effects of subcutaneous injections of glucocorticoids on amoeboid μglia in postnatal rats
38. The effects of subcutaneous injections of glucocorticoids on amoeboid microglia in postnatal rats
39. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease
40. Effects of estradiol-17beta on cholesterol metabolism in the rat: A study using a deuterium label and mass spectrometry
41. Inhibition of rat adjuvant-induced arthritis by ginkgetin, a biflavone from ginkgo biloba leaves
42. Phagocytosis is regulated by nitric oxide in murine μglia
43. β-amyloid peptides induce degeneration of cultured rat μglia
44. Microglial response to transient focal cerebral ischemia and immunocytochemical study on the rat cerebral cortex using anti-phosphtyrosine antibody
45. Estrogen enhances uptake of amyloid beta-protein by μglia derived from the human cortex
46. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
47. Ex vivo binding to glucocorticoid receptors in the thymus of the adrenalectomized rat
48. Expression of alpha2 macroglobulin receptor/low-density lipoprotein receptor-related protein (LRP) in rat μglial cells
49. Activation of μglial cells by beta-amyloid protein and interferon-gamma
50. Proliferation of glial-derived cells in defined media
51. Cognitive and noncognitive symptoms in dementia patients: Relationship to cortisol and dehydroepiandrosterone
52. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent fom the estrogenic properties
53. Glucocorticoid regulation of inflammation: The plot thickens
54. μglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor
55. Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain
56. μglia in the neurohypophysis associate with and endocytose terminal portions of neurosecretory neurons
57. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
58. The scavenger receptor CD163: Regulation, promoter structure and genomic organization
59. Synergism of glucocorticoids with granulocyte macrophage colony stimulating factor (GM-CSF) but not inteferon gamma (IFN-gamma) or interleukin-4 (IL-4) on induction of HLA class II expression on human monocytes
60. Risk of Alzheimer's disease and duration of NSAID use
61. Astrocytes and μglia respond to estrogen with increased apoE mRNA In vivo and In vitro
62. Corticosteroids enhance the binding of recombinant interferon-to cultured human monocytes
63. Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease: Lack of association between longitudinal and cross-sectional findings
64. Glucocorticoid- and mineralocorticoid receptors in μglial cells: The two receptors mediate differential effects of corticosteroids
65. Cortisol secretion and Alzheimer's disease progression: A preliminary report
66. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides
67. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1-42 pathogenesis